Iatrogenic Botulism Due to Therapeutic Botulinum Toxin A Injection in a Pediatric Patient

Authors:
  • JBJanice E. Brunstrom
    Janice E. Brunstrom
  • BRBrad A. Racette
    Brad A. Racette

Abstract
Botulinum toxin A is commonly used to reduce spasticity and dystonia in children with cerebral palsy. We report a pediatric patient who developed systemic botulism as a result of a severe overdose of the injected toxin (40 U/kg). This case highlights the importance of physicians having adequate knowledge of primate and human literature on the lethal dose, 50% of botulinum toxin A before injecting children.

This publication has 21 references indexed in Scilit: